SEC Form 4 · accession 0000914190-15-000216
NEPHROS INC · NEPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew Rosenberg
Director
Period of report
May 12, 2015
Accepted (ET)
May 14, 2015 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001196298
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 12, 2015 | P$0 | 200,000 | — | A | 789,695 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants (right to buy)F1 | $0.85 | May 12, 2015 | P | 100,000 | A | May 12, 2015 | May 18, 2020 | Common Stock | 100,000 | 100,000 | D |
| Non-Qualified Stock Option (right to buy)F2 | $0.79 | holding | — | — | — | — | May 16, 2024 | Common Stock | 48,864 | 48,864 | D |
Explanation of responses
- F1The reported securities have a purchase price of $0.67 per share of Common Stock. In addition, the reporting person received a Warrant to purchase a number of shares of Common Stock equal to 50% of the number of shares of Common Stock otherwise purchased. The reporting person purchased 200,000 shares of Common Stock and was issued related Warrants to acquire up to 50% of the number of shares of Common Stock (i.e., 100,000 Warrants).
- F2On May 16, 2014, the Company granted Mr. Rosenberg an option to purchase 48,864 shares of common stock of the Company (the "Option") under the Company's 2004 Stock Incentive Plan. The Option vested immediately upon the grant date with respect to one-third of the shares. The remainder of the Option vests in equal annual installments on each of the first and second anniversaries of the grant date.